Fred Burke Sells 747,102 Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) Stock

Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) insider Fred Burke sold 747,102 shares of the business's stock in a transaction dated Tuesday, May 27th. The shares were sold at an average price of $20.16, for a total transaction of $15,061,576.32. Following the completion of the sale, the insider now directly owns 551,724 shares of the company's stock, valued at approximately $11,122,755.84. This trade represents a 57.52% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Fred Burke also recently made the following trade(s):

• On Wednesday, May 28th, Fred Burke sold 138,705 shares of Guardian Pharmacy Services stock. The shares were sold at an average price of $20.16, for a total value of $2,796,292.80.

Guardian Pharmacy Services Price Performance

Shares of NYSE GRDN traded up $0.12 during midday trading on Monday, reaching $21.29. 249,308 shares of the company's stock traded hands, compared to its average volume of 168,739. The stock's 50 day simple moving average is $23.18 and its 200-day simple moving average is $22.01. Guardian Pharmacy Services, Inc. has a one year low of $14.16 and a one year high of $26.91.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last posted its earnings results on Monday, May 12th. The company reported $0.21 earnings per share for the quarter, missing analysts' consensus estimates of $0.22 by ($0.01). The business had revenue of $329.31 million during the quarter, compared to the consensus estimate of $321.21 million. Sell-side analysts forecast that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current fiscal year.

Institutional Investors Weigh In On Guardian Pharmacy Services

Hedge funds have recently made changes to their positions in the stock. R Squared Ltd purchased a new position in Guardian Pharmacy Services in the fourth quarter valued at about $30,000. BNP Paribas Financial Markets purchased a new position in shares of Guardian Pharmacy Services in the 4th quarter worth approximately $37,000. Compass Financial Services Inc purchased a new position in shares of Guardian Pharmacy Services in the 4th quarter worth approximately $58,000. JPMorgan Chase & Co. bought a new position in shares of Guardian Pharmacy Services during the 4th quarter worth approximately $77,000. Finally, Quantbot Technologies LP purchased a new stake in Guardian Pharmacy Services during the fourth quarter valued at approximately $81,000.

Analysts Set New Price Targets

Several research firms have commented on GRDN. Wall Street Zen downgraded Guardian Pharmacy Services from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Raymond James set a $28.00 price target on Guardian Pharmacy Services and gave the stock an "outperform" rating in a research report on Wednesday, May 14th. Finally, Truist Financial restated a "buy" rating and issued a $28.00 price objective (up from $25.00) on shares of Guardian Pharmacy Services in a report on Monday, May 19th.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.